Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Chai Discovery logo — Building frontier artificial intelligence to predict and rep...

Chai Discovery

Building frontier artificial intelligence to predict and reprogram the interactions between biochemi

Founded 2024 United States San Francisco, United States 45 employees Series C Total: $630.00M Biotechnology

General Information

Company Name Chai Discovery
Founded Year 2024
Location United States San Francisco, United States
Employees 45
Industries Biotechnology
Funding Stage Series C
Business Model B2B, SaaS, API
Revenue Model Subscription, Usage Based, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Chai Discovery. To contact Chai Discovery, visit chaidiscovery.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Chai Discovery compare?

A PDF of Chai Discovery and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Chai Discovery soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

New Partnership Nov 05, 2026

Chai Discovery announced a collaboration with Roche to apply their AI platform across discovery programs.

Award Received Oct 14, 2026

Chai Discovery has been named an AI Pioneer in the 2026 #Disruptors60.

Major Customer Win Oct 09, 2026

GSK expanded its work with Chai Discovery into a broader collaboration to support discovery efforts across its pipeline.

In The News Oct 07, 2026

Featured on Thenextweb: Rivercell raises $25M to build an AI model of how cells respond to drugs

Chai Discovery a competitor of yours? Have our desk watch it

About Chai Discovery

Chai Discovery, founded in 2024 and headquartered in the United States, operates at the cutting edge of Biotechnology. Their slogan, "Building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules," encapsulates their mission to revolutionize molecular interactions through advanced AI.

The company recently secured a substantial $130.00M Series B investment on 01 December 2025. This funding round attracted prominent investors such as Oak HC/FT, Emerson Collective, General Catalyst, Menlo Ventures, SV Angel, Thrive Capital, Open AI, Yosemite, Glade Brook Capital Partners, Lachy Groom, Neo vc, and Dimension Capital Management.

Chai Discovery's innovative approach and solid financial backing highlight its potential to become a leader in leveraging artificial intelligence for biochemistry advancements.

Business keywords: Biochemical Interactions, Molecular Prediction, Computational Biology, Molecular Reprogramming, AI in Healthcare, Predictive Analytics, Bioinformatics, Drug Discovery, Molecular Engineering, Life Sciences, Biological Data Analysis, Machine Learning in Biology

Services & Products

AI-driven molecule engineering
Antibody design against challenging targets
Therapeutic development with atomic precision

Target Customers

Biotechnology companies Pharmaceutical companies Healthcare institutions Research labs specializing in drug development

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $400.00M 9
Battery Ventures Index Ventures Kleiner Perkins
Battery Ventures, Index Ventures +7
15 Jul 2026
Series B $130.00M 12
Oak HC/FT Emerson Collective General Catalyst
Oak HC/FT, Emerson Collective +10
01 Dec 2025
Series A $70.00M 13
DCVC DST Global Menlo Ventures
DCVC, DST Global +11
01 Aug 2025
Seed $30.00M 4
Thrive Capital Open AI
Thrive Capital, Open AI +2
01 Sep 2024

Latest News

View All
Rivercell raises $25M to build an AI model of how cells respond to drugs — Thenextweb
Rivercell raises $25M to build an AI model of how cells respond to drugs
Thenextweb Oct 07, 2026
An OpenAI researcher is leaving to build a $2bn AI drug startup that has no name yet — Thenextweb
An OpenAI researcher is leaving to build a $2bn AI drug startup that has no name yet
Thenextweb Jul 15, 2026
Chai Discovery raises $400M at $3.8bn as AI drug discovery moves from promise to deployment — Thenextweb
Chai Discovery raises $400M at $3.8bn as AI drug discovery moves from promise to deployment
Thenextweb Jul 15, 2026
Biyoteknoloji girişimi Chai Discovery, 130 milyon dolar yatırım aldı — Webrazzi
Biyoteknoloji girişimi Chai Discovery, 130 milyon dolar yatırım aldı
Webrazzi Dec 16, 2025
Genesis says its new AI model bests AlphaFold 3, seeing synthetic physics data as key — Endpoints.news
Genesis says its new AI model bests AlphaFold 3, seeing synthetic physics data as key
Endpoints.news Oct 28, 2025
BoltzGen Democratizes AI Therapeutic Design, Expands Druggable Universe — Genengnews.com
BoltzGen Democratizes AI Therapeutic Design, Expands Druggable Universe
Genengnews.com Oct 27, 2025

Chai Discovery Alternatives & Competitors

View All Alternatives
Chai Discovery vs
Octant
Octant United States

Developing synthetic technology and applying next-generation DNA sequencing, gene synthesis, and gen...

Series B
69 employees
Biotechnology, Life Sciences
Chai Discovery vs
Genesis Molecular AI
Genesis Molecular AI United States

Unifying AI and Biotech to accelerate the discovery of new medicines

157 employees
AI, Biotechnology
Chai Discovery vs
MindWalk Corp. (formerly BioStrand)
MindWalk Corp. (formerly BioStrand) United States

This page is no longer actively updated. For future updates follow: MindWalk Holdings Corp.

Grant
4 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Chai Discovery

Building frontier artificial intelligence to predict and reprogram the interactions between biochemi
Chai Discovery was founded in 2024.
Chai Discovery is headquartered in San Francisco, United States.
Chai Discovery operates in Biotechnology. Its work centres on Biochemical Interactions, Molecular Prediction, Computational Biology and Molecular Reprogramming. Its customers include Biotechnology companies, Pharmaceutical companies and Healthcare institutions.
Chai Discovery has a B2B, SaaS and API business model. Its revenue comes from Subscription, Usage Based and Licensing.
Chai Discovery has approximately 45 employees.
Chai Discovery has completed 4 funding rounds, raising a total of $630.00M. The latest funding stage is Series C.
Chai Discovery offers: AI-driven molecule engineering, Antibody design against challenging targets, Therapeutic development with atomic precision.
Top alternatives and competitors to Chai Discovery include Octant, Genesis Molecular AI, MindWalk Corp. (formerly BioStrand), Latent Labs, A-Alpha Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Chai Discovery and Octant are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Chai Discovery, https://bouncewatch.com/company/chai-discovery, updated 5 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout